Randomized study of antiinflammatory and immune-modulatory effects of enteral immunonutrition during concurrent chemoradiotherapy for esophageal cancer

Nutrition and Cancer

Volumn 66, Issue 1, 2014, Pages 1-5

  Sunpaweravong, Somkiat ^a   Puttawibul, Puttisak ^a   Ruangsin, Sakchai ^a   Laohawiriyakamol, Supparerk ^a   Sunpaweravong, Patrapim ^a   Sangthawan, Duangjai ^a   Pradutkanchana, Jintana ^a   Raungkhajorn, Ponpis ^a   Geater, Alan ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CISPLATIN; FLUOROURACIL; GAMMA INTERFERON; GLUTAMINE; INTERLEUKIN 10; INTERLEUKIN 6; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; ENTERIC FEEDING; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; HUMAN; IMMUNOMODULATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; NEUTROPHIL COUNT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ADULT; AGED; ARGININE; C-REACTIVE PROTEIN; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; ENTERAL NUTRITION; ESOPHAGEAL NEOPLASMS; FATTY ACIDS, OMEGA-3; FEMALE; FLUOROURACIL; GLUTAMINE; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84891827719     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2014.847473     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J, and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108, 2005.
2. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, et al.: Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366, 2074-2084, 2012.
3. Mak RH, Mamon HJ, Ryan DP, Miyamoto DT, Ancukiewicz M, et al.: Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older. Dis Esophagus 23, 316-323, 2010.
4. Martin JM and Stapleton RD: Omega-3 fatty acids in critical illness. Nutr Rev 68, 531-541, 2010.
5. Newsholme P: Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection? J Nutr 131, 2515S-2522S, 2001.
6. Nieves C Jr and Langkamp-Henken B: Arginine and immunity: A unique perspective. Biomed Pharmacother 56, 471-482, 2002.
7. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, et al.: Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26, 1086-1092, 2008.
8. Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, et al.: CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13, 176-181, 2003.
9. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, et al.:New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 45, 228-247, 2009.
10. Margolis M, Alexander P, Trachiotis GD, Gharagozloo F, and Lipman T: Percutaneous endoscopic gastrostomy before multimodality therapy in patients with esophageal cancer. Ann Thorac Surg 76, 1694-1697, 2003.
11. Miyata H, Yano M, Yasuda T, Hamano R, Yamasaki M, et al.: Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer. Clin Nutr 31, 330-336, 2012.
12. MotooriM, YanoM, Yasuda T, Miyata H, Peng YF, et al.: Relationship between immunological parameters and the severity of neutropenia and effect of enteral nutrition on immune status during neoadjuvant chemotherapy on patients with advanced esophageal cancer. Oncology 83, 91-100, 2012.
13. Jho DH, Cole SM, Lee EM, and Espat NJ: Role of omega-3 fatty acid supplementation in inflammation and malignancy. Integr Cancer Ther 3, 98-111, 2004.
14. Silva Jde A, Trindade EB, Fabre ME, Menegotto VM, Gevaerd S, et al.: Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients. Nutr Cancer 64, 267-273, 2012.
15. Finocchiaro C, Segre O, Fadda M, Monge T, Scigliano M, et al.: Effect of n-3 fatty acids on patients with advanced lung cancer: A double-blind, placebo-controlled study. Br J Nutr 108, 327-333, 2012.
16. van der Meij BS, Langius JA, Smit EF, Spreeuwenberg MD, von Blomberg BM, et al.: Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J Nutr 140, 1774-1780, 2010.
17. Boelens PG, Houdijk AP, Fonk JC, Nijveldt RJ, Ferwerda CC, et al.: Glutamine-enriched enteral nutrition increases HLA-DR expression on monocytes of trauma patients. J Nutr 132, 2580-2586, 2002.
18. Berger MM and Chioĺero RL: Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med 35, S584-S590, 2007.
19. Kudsk KA, Wu Y, Fukatsu K, Zarzaur BL, Johnson CD, et al.: Glutamineenriched total parenteral nutrition maintains intestinal interleukin-4 and mucosal immunoglobulin A levels. J Parenter Enteral Nutr 24, 270-274, 2000.
20. Curi R, Lagranha CJ, Doi SQ, Sellitti DF, Procopio J, et al.: Molecular mechanisms of glutamine action. J Cell Physiol 204, 392-401, 2005.
21. Popovic PJ, Zeh HJ 3rd, and Ochoa JB: Arginine and immunity. J Nutr 137, 1681S-1686S, 2007.
22. Bronte V and Zanovello P: Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 5, 641-654, 2005.
23. Ochoa JB and Makarenkova V: T lymphocytes. Crit Care Med 33, S510-S513, 2005.
24. Yeh CL, Yeh SL, Lin MT, and Chen WJ: Effects of arginine-enriched total parenteral nutrition on inflammatory-related mediator and T-cell population in septic rats. Nutrition 18, 631-635, 2002.
25. CoeffierMandD́echelotte P: Combined infusion of glutamine and arginine: Does it make sense? Curr Opin Clin Nutr Metab Care 13, 70-74, 2010.
26. Minami Y, Miyata H, Doki Y, Yano M, Yamasaki M, et al.: Omega-3 fatty acid-containing diet (Racol) reduces toxicity of chemoradiation therapy for patients with esophageal cancer.Gan To Kagaku Ryoho 35, 437-440, 2008.
27. van der Meij BS, Langius JA, Spreeuwenberg MD, Slootmaker SM, Paul MA, et al.: Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: An RCT. Eur J Clin Nutr 66, 399-404, 2012.
28. Trabal J, Leyes P, Forga M, and Maurel J: Potential usefulness of an EPAenriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition. Nutr Hosp 25, 736-740, 2010.
29. Daniele B, Perrone F, Gallo C, Pignata S, De Martino S, et al.: Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: A double blind, placebo controlled, randomised trial. Gut 48, 28-33, 2001.
30. Murphy RA, Mourtzakis M, Chu QS, Baracos VE, Reiman T, and Mazurak VC: Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced non-small cell lung cancer. Cancer 117, 3774-3780, 2011.
31. Seyfried TN and Shelton LM: Cancer as a metabolic disease. Nutr Metab (Lond) 7, 7, 2010.
32. Bossola M, Pacelli F, Rosa F, Tortorelli A, Doglietto GB. Does nutrition support stimulate tumor growth in humans? Nutr Clin Pract 2, 174-180, 2011.